Page last updated: 2024-08-24

tenofovir and emtricitabine, tenofovir disoproxil fumarate drug combination

tenofovir has been researched along with emtricitabine, tenofovir disoproxil fumarate drug combination in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (10.00)29.6817
2010's24 (60.00)24.3611
2020's12 (30.00)2.80

Authors

AuthorsStudies
Hidalgo, A; Palacios, R; Rivero, A; Santos, J; Terrón, A1
del Arco, A; Gálvez, MC; Gutiérrez-Ravé, V; Hidalgo, C; Lozano, F; Muñoz, L; Palacios, R; Ríos, MJ; Rivero, A; Santos, J1
Barr, JR; Cong, ME; Folks, TM; García-Lerma, JG; Hanson, DL; Heneine, W; Holder, A; Kuklenyik, Z; Lipscomb, J; Martin, A; Masciotra, S; Mitchell, J; Otten, R; Pau, CP; Paxton, L; Youngpairoj, AS; Zheng, Q1
Bateman, C1
Brüning, A; Burger, P; Gingelmaier, A; Mylonas, I1
Fidler, S; Fisher, M; McCormack, S1
De Clercq, E3
Haire, B; Jordens, CF; Kaldor, J1
Grabczewska, E; Olczak, A1
Adams, DR; Butler, K; Cong, ME; Garcia-Lerma, JG; Hanson, D; Hendry, RM; Heneine, W; Kersh, EN; Luo, W; McNicholl, JM; Youngpairoj, AS; Zheng, Q1
Holmes, D1
Herold, BC; Kiser, PF; Mesquita, PM1
Hawkes, N1
Brown, ER; Chirenje, ZM; Gomez, K; Liu, K; Marrazzo, J; Mensch, BS; Patterson, K; Piper, J; van der Straten, A1
Moodley, J; Naidoo, S; Ramjee, G1
Etima, J; Hartmann, M; Mensch, B; Montgomery, ET; Musara, P; van der Straten, A; Woeber, K1
Dodoo, AN; Lartey, M; Leufkens, HG; Nartey, ET; Tetteh, RA; Yankey, BA1
Beauchamp, G; Breaud, A; Clarke, W; Cloherty, GA; Emel, L; Eshleman, SH; Fields, SD; Hendrix, CW; Hightow-Weidman, L; Marzinke, MA; Piwowar-Manning, E; Rose, S; Shoptaw, S; Siegel, M; Wheeler, D; Zhang, Y1
Amico, KR; Anderson, PL; Beymer, M; Bolan, RK; Bushman, L; Dierst-Davies, R; Flynn, R; Jordan, WC; Kofron, R; Landovitz, RJ; Lee, DP; Psaros, C; Rooney, J; Tseng, CH; Wohl, AR1
Abbai, NS; Naidoo, S; Nyirenda, M; Ramjee, G1
Reinke, T1
Kabwigu, S; Kamira, B; Kemigisha, D; Kiweewa Matovu, F; Mubiru, MC; Muwawu, R; Nakabiito, C; Nakyanzi, T; Wynne, J1
Amico, KR; Bekker, LG; Chitwarakorn, A; Dye, BJ; Grant, RM; Hendrix, CW; Holtz, TH; Hughes, JP; Li, M; Mannheimer, S; Marzinke, M; Ojeda, VD; Wilson, E1
Brown, K; Cunningham, D; De Wit, S; Eron, JJ; Hufkens, V; Jezorwski, J; Lathouwers, E; Opsomer, M; Orkin, C; Petrovic, R; Post, FA; Pulido, F; Van Landuyt, E1
Desta, Z; Gufford, BT; Liu, SN1
Armstrong, WS; Del Rio, C1
Anderson, PL; Brainard, DM; Brinson, C; Callebaut, C; Clarke, A; Coll, P; Collins, SE; Das, M; De Wet, JJ; DeJesus, E; Ebrahimi, R; Grant, RM; Hare, CB; Jessen, H; Mathias, A; Mayer, KH; McCallister, S; Molina, JM; Mounzer, KC; Post, FA; Ruane, PJ; Thompson, MA; Wong, P; Zhong, L1
Ambrosioni, J; Laguno, M; Liegeon, G; Miró, JM; Petit, E1
Benet, LZ; Gandhi, M; Koss, CA; Kuncze, K; Louie, A; Okochi, H; Phung, N; Spinelli, MA; Tallerico, RM; Zhang, K1
Malisheni, M; Murewanhema, G; Takah, NF1
Carneiro, PB; D'Angelo, AB; Grov, C; Johnson, J; Westmoreland, DA1
Bonnichsen, MH; Bye, W; Post, JJ; Tschuchnigg, M1
Dickson, S; Gabriel, N; Hernandez, I1
Avorn, J; Barenie, RE; Kesselheim, AS; Tessema, FA1

Reviews

6 review(s) available for tenofovir and emtricitabine, tenofovir disoproxil fumarate drug combination

ArticleYear
Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?
    Medicinal research reviews, 2012, Volume: 32, Issue:4

    Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir

2012
[HIV preexposure prophylaxis].
    Przeglad epidemiologiczny, 2012, Volume: 66, Issue:1

    Topics: Adenine; Administration, Oral; Animals; Anti-HIV Agents; Chemoprevention; Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Male; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir

2012
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Drug safety, 2017, Volume: 40, Issue:4

    Topics: Animals; Anti-HIV Agents; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Pre-Exposure Prophylaxis; Tenofovir

2017
Primary HIV-1 infection in users of pre-exposure prophylaxis.
    The lancet. HIV, 2021, Volume: 8, Issue:3

    Topics: Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV Seropositivity; HIV-1; Humans; Pre-Exposure Prophylaxis; Tenofovir; Viral Load

2021
The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
    The Pan African medical journal, 2021, Volume: 38

    Topics: Africa South of the Sahara; Anti-HIV Agents; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Medication Adherence; Pre-Exposure Prophylaxis; Randomized Controlled Trials as Topic; Tenofovir

2021
Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections.
    Viruses, 2021, 12-02, Volume: 13, Issue:12

    Topics: Alanine; Anti-HIV Agents; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hepatitis B; History, 20th Century; History, 21st Century; HIV; HIV Infections; Humans; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; Tenofovir

2021

Trials

7 trial(s) available for tenofovir and emtricitabine, tenofovir disoproxil fumarate drug combination

ArticleYear
Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?
    AIDS and behavior, 2016, Volume: 20, Issue:11

    Topics: Administration, Oral; Adult; Anti-HIV Agents; Deception; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; HIV Infections; Humans; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Self Disclosure; South Africa; Tenofovir; Uganda; Young Adult; Zimbabwe

2016
Sharing of Investigational Drug Among Participants in the Voice Trial.
    AIDS and behavior, 2016, Volume: 20, Issue:11

    Topics: Administration, Oral; Adult; Anti-HIV Agents; Double-Blind Method; Drugs, Investigational; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Medication Adherence; Pre-Exposure Prophylaxis; South Africa; Substance-Related Disorders; Tenofovir; Vaginal Creams, Foams, and Jellies; Young Adult

2016
Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:7

    Topics: Anti-HIV Agents; Drug Resistance, Multiple, Viral; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Male; Medication Adherence; Pre-Exposure Prophylaxis; Tenofovir

2017
Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa.
    AIDS and behavior, 2018, Volume: 22, Issue:7

    Topics: Administration, Intravaginal; Administration, Oral; Adult; Cross-Sectional Studies; Developing Countries; Double-Blind Method; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seronegativity; Humans; Incidence; Risk Factors; South Africa; Tenofovir; Unsafe Sex; Vaginosis, Bacterial; Young Adult

2018
Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study.
    HIV clinical trials, 2018, Volume: 19, Issue:5

    Topics: Administration, Intravaginal; Administration, Oral; Adult; Albuterol, Ipratropium Drug Combination; Anti-HIV Agents; Clinical Trials as Topic; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; HIV Infections; Humans; Longitudinal Studies; Patient Participation; Tenofovir; Uganda

2018
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/
    Antiviral research, 2019, Volume: 170

    Topics: Adenine; Adult; Aged; Alanine; Anti-HIV Agents; Cobicistat; Darunavir; Drug Combinations; Drug Substitution; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Protease Inhibitors; Sustained Virologic Response; Tablets; Tenofovir; Treatment Outcome; Viral Load

2019
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
    Lancet (London, England), 2020, 07-25, Volume: 396, Issue:10246

    Topics: Adenine; Adult; Anti-HIV Agents; Double-Blind Method; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Europe; Female; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; North America; Placebos; Pre-Exposure Prophylaxis; Prevalence; Safety; Sexual and Gender Minorities; Tenofovir; Treatment Outcome

2020

Other Studies

27 other study(ies) available for tenofovir and emtricitabine, tenofovir disoproxil fumarate drug combination

ArticleYear
[Simply convincing. New fixed combination for HIV therapy].
    MMW Fortschritte der Medizin, 2005, Apr-25, Volume: 147 Spec No 1

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Viral; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Patient Compliance; Practice Guidelines as Topic; Survival Rate; Tenofovir

2005
Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:2

    Topics: Adenine; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Sleep Initiation and Maintenance Disorders; Tenofovir

2008
Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:4

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Central Nervous System; Cohort Studies; Creatinine; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; HIV-1; Humans; Kidney; Lamivudine; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Risk Factors; RNA, Viral; Tenofovir; Viral Load

2009
Generic Truvada approved.
    AIDS patient care and STDs, 2009, Volume: 23, Issue:5

    Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Drug Approval; Drug Combinations; Drugs, Generic; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; United States; United States Food and Drug Administration

2009
Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.
    Science translational medicine, 2010, Jan-13, Volume: 2, Issue:14

    Topics: Adenine; Administration, Oral; Animals; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Kinetics; Leukocytes, Mononuclear; Macaca; Organophosphonates; Organophosphorus Compounds; Proportional Hazards Models; Rectum; Research Design; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2010
Findings in humanized-mouse model suggest benefit of further studies in HIV pre-exposure prophylaxis.
    Expert review of clinical immunology, 2010, Volume: 6, Issue:2

    Topics: Adenine; Animals; Anti-HIV Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Deoxycytidine; Disease Models, Animal; Drug Combinations; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV; HIV Antibodies; HIV Infections; Humans; Infection Control; Liver Transplantation; Mice; Occupational Exposure; Organophosphonates; Organophosphorus Compounds; Tenofovir; Thymus Gland; Transplantation Chimera

2010
Still a long wait for approved HIV-protective gel.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2010, Sep-07, Volume: 100, Issue:9

    Topics: Adenine; Antiviral Agents; Deoxycytidine; Drug Approval; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Technology Transfer; Tenofovir; Vaginal Creams, Foams, and Jellies

2010
Early end for FEM-PrEP HIV prevention trial.
    AIDS patient care and STDs, 2011, Volume: 25, Issue:6

    Topics: Adenine; Administration, Oral; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Kenya; Organophosphonates; Organophosphorus Compounds; Patient Compliance; Randomized Controlled Trials as Topic; South Africa; Tanzania; Tenofovir

2011
The HIV reverse transcriptase inhibitor tenofovir induces cell cycle arrest in human cancer cells.
    Investigational new drugs, 2012, Volume: 30, Issue:4

    Topics: Adenine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cytostatic Agents; Deoxycytidine; DNA Breaks, Double-Stranded; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Histones; HIV Reverse Transcriptase; Humans; Organophosphonates; Organophosphorus Compounds; Ovarian Neoplasms; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors

2012
The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK.
    International journal of STD & AIDS, 2012, Volume: 23, Issue:1

    Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir; United Kingdom

2012
How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention.
    The American journal of bioethics : AJOB, 2012, Volume: 12, Issue:6

    Topics: Adenine; Administration, Intravaginal; Administration, Oral; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ethical Analysis; Ethical Theory; Ethics, Research; Evidence-Based Medicine; Female; Gels; Guidelines as Topic; Health Services Accessibility; Health Services Needs and Demand; HIV Infections; Homosexuality, Male; Humans; Male; Organophosphonates; Organophosphorus Compounds; Primary Prevention; Randomized Controlled Trials as Topic; Research Subjects; Sex Work; Tenofovir; Therapeutic Equipoise; United States; United States Food and Drug Administration

2012
Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.
    The Journal of infectious diseases, 2012, Sep-01, Volume: 206, Issue:5

    Topics: Adenine; Alanine; Animals; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytokines; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Longitudinal Studies; Macaca mulatta; Male; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Statistics, Nonparametric; Tenofovir; Viremia

2012
FDA paves the way for pre-exposure HIV prophylaxis.
    Lancet (London, England), 2012, Jul-28, Volume: 380, Issue:9839

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Primary Prevention; Tenofovir; United States; United States Food and Drug Administration

2012
A perspective on progress and gaps in HIV prevention science.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:11

    Topics: Adenine; Administration, Oral; Administration, Topical; Anal Canal; Anti-HIV Agents; Chemoprevention; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Immunity, Innate; Male; Medication Adherence; Mouth Mucosa; Mucous Membrane; Organophosphonates; Organophosphorus Compounds; Sexual Partners; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies

2012
FDA must publish data on safety and efficacy of prophylactic AIDS drug, court rules.
    BMJ (Clinical research ed.), 2013, Aug-19, Volume: 347

    Topics: Access to Information; Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Humans; Organophosphonates; Organophosphorus Compounds; Publishing; Tenofovir; United States; United States Food and Drug Administration

2013
Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants' Explanations for Dishonesty.
    AIDS and behavior, 2017, Volume: 21, Issue:2

    Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-HIV Agents; Clinical Trials, Phase II as Topic; Deception; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Epidemics; Female; HIV Infections; Humans; Medication Adherence; Qualitative Research; Self Report; Sexual Partners; South Africa; Tenofovir; Uganda; Young Adult; Zimbabwe

2017
Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
    Journal of acquired immune deficiency syndromes (1999), 2017, 12-15, Volume: 76, Issue:5

    Topics: Adolescent; Adult; Biomarkers; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Los Angeles; Male; Patient Compliance; Pre-Exposure Prophylaxis; Tenofovir; Transgender Persons; Young Adult

2017
Regimen Change: Gilead's TAF Drugs Toppling TDFs in HIV Treatment.
    Managed care (Langhorne, Pa.), 2017, Volume: 26, Issue:9

    Topics: Adenine; Alanine; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome

2017
Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study.
    Journal of acquired immune deficiency syndromes (1999), 2019, 09-01, Volume: 82, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Condoms; Directly Observed Therapy; Disclosure; Drug Therapy, Combination; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Risk-Taking; Sexual and Gender Minorities; Social Networking; South Africa; Surveys and Questionnaires; Tenofovir; Thailand; United States; Young Adult

2019
Probenecid-Boosted Tenofovir: A Physiologically-Based Pharmacokinetic Model-Informed Strategy for On-Demand HIV Preexposure Prophylaxis.
    CPT: pharmacometrics & systems pharmacology, 2020, Volume: 9, Issue:1

    Topics: Anti-HIV Agents; Drug Interactions; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Models, Biological; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Pre-Exposure Prophylaxis; Probenecid; Tenofovir

2020
How Much Are We Willing to Pay for Preexposure Prophylaxis in the United States?
    Annals of internal medicine, 2020, 05-05, Volume: 172, Issue:9

    Topics: Adenine; Alanine; Anti-HIV Agents; Cost-Benefit Analysis; Decision Making, Shared; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Health Services Accessibility; HIV Infections; Humans; Pre-Exposure Prophylaxis; Tenofovir; United States

2020
Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART.
    Drug testing and analysis, 2021, Volume: 13, Issue:7

    Topics: Adenine; Anti-HIV Agents; Chromatography, High Pressure Liquid; Cobicistat; Dose-Response Relationship, Drug; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hair; Hair Analysis; HIV Infections; Humans; Ritonavir; Tandem Mass Spectrometry; Tenofovir; Tissue Distribution

2021
Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
    AIDS patient care and STDs, 2021, Volume: 35, Issue:8

    Topics: Adenine; Alanine; Anti-HIV Agents; Cohort Studies; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Male; Pre-Exposure Prophylaxis; Tenofovir

2021
Pill related oesophagitis due to tenofovir disproxil fumarate/emtricitabine (Truvada) HIV pre-exposure prophylaxis.
    Internal medicine journal, 2022, Volume: 52, Issue:6

    Topics: Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Esophagitis; Fumarates; HIV Infections; Humans; Pre-Exposure Prophylaxis; Tenofovir

2022
The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death.
    Viruses, 2022, 09-07, Volume: 14, Issue:9

    Topics: Anniversaries and Special Events; Anti-HIV Agents; Antiviral Agents; Cidofovir; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Nucleosides; Organophosphonates; Prodrugs; Tenofovir

2022
Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide.
    AIDS (London, England), 2022, 12-01, Volume: 36, Issue:15

    Topics: Anti-HIV Agents; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Tenofovir

2022
Federal Funding For Discovery And Development Of Costly HIV Drugs Was Far More Than Previously Estimated.
    Health affairs (Project Hope), 2023, Volume: 42, Issue:5

    Topics: Anti-HIV Agents; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Pharmaceutical Preparations; Tenofovir

2023